These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6213588

  • 1. The development of an oral prodrug, SR-2545, of the 2-nitroimidazole radiosensitizer SR-2508.
    Coleman CN, Lee WW, Constine LS, Brown JM.
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):431-4. PubMed ID: 6213588
    [Abstract] [Full Text] [Related]

  • 2. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration.
    Murayama C, Suzuki A, Sato C, Tanabe Y, Miyata Y, Shoji T, Suzuki T, Sakaguchi M, Mori T.
    Int J Radiat Oncol Biol Phys; 1992; 22(3):557-60. PubMed ID: 1531214
    [Abstract] [Full Text] [Related]

  • 3. KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics.
    Sasai K, Shibamoto Y, Takahashi M, Zhou L, Hori H, Nagasawa H, Shibata T, Inayama S, Abe M.
    Cancer Chemother Pharmacol; 1990; 26(2):112-6. PubMed ID: 2140730
    [Abstract] [Full Text] [Related]

  • 4. SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use.
    Brown JM, Yu NY, Brown DM, Lee WW.
    Int J Radiat Oncol Biol Phys; 1981 Jun; 7(6):695-703. PubMed ID: 6457018
    [No Abstract] [Full Text] [Related]

  • 5. [Radiosensitization by hypoxic cell radiosensitizer--present status of radiosensitizer].
    Murayama C, Mori T.
    Gan No Rinsho; 1990 Oct; 36(13):2249-54. PubMed ID: 2147449
    [Abstract] [Full Text] [Related]

  • 6. Additivity of radiosensitization by the combination of SR 2508 (etanidazole) and Ro 03-8799 (pimonidazole) in a murine tumor system.
    Honess DJ, Wasserman TH, Workman P, Ward R, Bleehen NM.
    Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):671-5. PubMed ID: 2971028
    [Abstract] [Full Text] [Related]

  • 7. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
    Murayama C, Suzuki A, Suzuki T, Miyata Y, Sakaguchi M, Tanabe Y, Tanaka N, Mori T.
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
    [Abstract] [Full Text] [Related]

  • 8. The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazole.
    White RA, Workman P, Brown JM.
    Radiat Res; 1980 Dec; 84(3):542-61. PubMed ID: 6450431
    [No Abstract] [Full Text] [Related]

  • 9. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity.
    Oya N, Shibamoto Y, Sasai K, Shibata T, Murata R, Takagi T, Iwai H, Suzuki T, Abe M.
    Int J Radiat Oncol Biol Phys; 1995 Aug 30; 33(1):119-27. PubMed ID: 7642409
    [Abstract] [Full Text] [Related]

  • 10. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.
    Sasai K, Shibamoto Y, Takahashi M, Abe M, Wang J, Zhou L, Nishimoto S, Kagiya T.
    Jpn J Cancer Res; 1989 Nov 30; 80(11):1113-8. PubMed ID: 2532634
    [Abstract] [Full Text] [Related]

  • 11. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
    Murayama C, Suzuki A, Sato C, Tanabe Y, Shoji T, Miyata Y, Nishio A, Suzuki T, Sakaguchi M, Mori T.
    Int J Radiat Oncol Biol Phys; 1993 Jun 15; 26(3):433-43. PubMed ID: 8514541
    [Abstract] [Full Text] [Related]

  • 12. [Radiosensitizer: hypoxic cell radiosensitizer].
    Mori T.
    Gan To Kagaku Ryoho; 1989 Apr 15; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
    [Abstract] [Full Text] [Related]

  • 13. [Recent advances in hypoxic cell radiosensitizer].
    Ono K, Takahashi M, Nishidai T, Shibamoto Y, Abe M.
    Gan No Rinsho; 1983 Oct 15; 29(13):1608-12. PubMed ID: 6230470
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
    Workman P.
    Cancer Clin Trials; 1980 Oct 15; 3(3):237-51. PubMed ID: 7438321
    [Abstract] [Full Text] [Related]

  • 15. Radiosensitizing activity and pharmacokinetics of multiple dose administered KU-2285 in peripheral nerve tissue in mice.
    Iwai H, Matsuno E, Sasai K, Shibamoto Y, Abe M.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):591-4. PubMed ID: 8005821
    [Abstract] [Full Text] [Related]

  • 16. Radiosensitization by the combination of etanidazole (SR-2508) and pimonidazole (Ro 03-8799) in human tumor xenografts.
    Taghian A, Lespinasse F, Guichard ME.
    Int J Radiat Oncol Biol Phys; 1991 Nov 15; 21(6):1535-40. PubMed ID: 1834621
    [Abstract] [Full Text] [Related]

  • 17. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
    Herman TS, Teicher BA, Pfeffer MR, Khandekar V, Chapnick RM, Kalick GS, Rabow A.
    Radiat Res; 1990 Oct 15; 124(1):28-33. PubMed ID: 2146699
    [Abstract] [Full Text] [Related]

  • 18. 4-Fluorobenzylamine and phenylalanine methyl ester conjugates of 2-nitroimidazole: evaluation as hypoxic cell radiosensitizers.
    Garg PK, Garg S, Degraff WG, Zalutsky MR, Mitchell JB.
    Int J Radiat Oncol Biol Phys; 1992 Oct 15; 22(3):593-6. PubMed ID: 1531220
    [Abstract] [Full Text] [Related]

  • 19. The effect of timing on chemosensitization by clinical levels of SR-2508.
    Hirst DG, Horsman MR, Brown JM, Hazlehurst JL.
    Int J Radiat Oncol Biol Phys; 1984 Sep 15; 10(9):1641-5. PubMed ID: 6237082
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione.
    DeGraff WG, Russo A, Gamson J, Mitchell JB.
    Int J Radiat Oncol Biol Phys; 1989 Apr 15; 16(4):1021-4. PubMed ID: 2522917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.